Category Biodiversity/Genetic Resources/Biotech

TRIPS Council To Discuss LDC Waiver Extension, Innovation This Week

The World Trade Organization committee on intellectual property and trade this week will discuss a range of issues including a request by least-developed countries to extend the time before they are required to enforce rules on IP and pharmaceuticals. Other issues include a discussion of IP and innovation, and a moratorium on complaints about government actions that do not violate WTO rules but may harm trade.

Alternative Summit Offers Ideas For Trade Agreements, G7, Amid 40,000 Protesters

MUNICH -- Just days before leaders of the Group of 7 (G7) industrialised countries gather in the well-guarded Bavarian Castle Elmau, a broad coalition of organisations invited free trade critics to an International Summit for Alternatives in Munich. Speaking there, Jean Ziegler, well-known former UN rapporteur for the right to food, shrugged off the possible effects of the G7 Summit.

WIPO’s New Act For GIs: Not Much Ado About Place Names?

Recent negotiations at the World Intellectual Property Organization to create a new Act for the protection of geographical indications were intensive, with the outcome considered a landmark breakthrough by negotiators and a blow to the UN agency’s legitimacy by others. But a search on global coverage of and reactions to the new agreement raises the question of whether it has attracted broader attention.

An Interview With WIPO Director General Francis Gurry On The New Lisbon Act For GIs

Members of the Lisbon Agreement for the Protection of Appellations of Origin and their International Registration on 20 May agreed on a new Act of the agreement, extending protection previously granted only to appellations of origins to geographical indications. The World Intellectual Property Organization is responsible for this agreement. After the signing ceremony at WIPO, Intellectual Property Watch sat down with WIPO Director General Francis Gurry to discuss the new Act.

New Act Protecting Geographical Indications Adopted At WIPO

Today, a small number of World Intellectual Property Organization members adopted a new Geneva Act of a treaty protecting appellations of origin and geographical indications. The Act is the revision of a previous treaty which only covered appellations of origin. This adoption was made to the dismay of other WIPO members, which despite efforts to accommodate their views could not reconcile being denied the right to vote in a United Nations body. They said the agreement among a few members could affect all.

WHA68: Global Vaccine Plan Lagging; New Proposal To Lower Prices

An assessment of the World Health Organization Global Vaccine Action Plan aimed at delivering vaccination to all and boosting research into new vaccines found implementation to be “far off-track” in some areas. Today at the World Health Assembly, Libya put forward a new proposal at the Assembly to reduce vaccine prices and increase availability in developing countries.

France, Italy, Heavyweights Of Lisbon Appellations Of Origin System; Africa Struggling

A small number of World Intellectual Property Organization members this week are negotiating to expand a treaty to protect geographical indications, products like Champagne. Under the old treaty, which protects appellations of origin, over half of the registrations are in France, and another large amount in Italy. According to an analysis, many of the 28 members of the treaty have zero or very few registrations, raising the question of how the new GI protection will be different if agreed.

Ebola R&D, Antibiotic Resistance, Neglected Diseases Among Issues At This Year’s World Health Assembly

The annual World Health Assembly opens next week with a focus on antimicrobial resistance, the Ebola outbreak, and research and development. Other subject of interests will be World Health Organization engagement with outside stakeholders, such as non-governmental organisations and the private sector, and a potential pooled fund for research and development for neglected diseases.